State Street Corp Prothena Corp Public LTD CO Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, State Street Corp holds 1,674,909 shares of PRTA stock, worth $25.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,674,909
Previous 1,932,472 13.33%
Holding current value
$25.5 Million
Previous $39.9 Million 29.75%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$16.73 - $24.79 $4.31 Million - $6.38 Million
-257,563 Reduced 13.33%
1,674,909 $28 Million
Q2 2024

Aug 14, 2024
SELL
$19.54 - $26.15 $30.1 Million - $40.3 Million
-1,541,524 Reduced 44.37%
1,932,472 $39.9 Million
Q1 2024

May 15, 2024
BUY
$24.75 - $40.66 $17.7 Million - $29.1 Million
715,432 Added 25.93%
3,473,996 $86.1 Million
Q4 2023

Feb 14, 2024
BUY
$32.31 - $52.32 $20.9 Million - $33.9 Million
648,331 Added 30.72%
2,758,564 $100 Million
Q3 2023

Nov 14, 2023
BUY
$47.3 - $70.6 $11.2 Million - $16.7 Million
236,555 Added 12.63%
2,110,233 $102 Million
Q2 2023

Aug 14, 2023
SELL
$48.26 - $78.59 $11 Million - $18 Million
-228,780 Reduced 10.88%
1,873,678 $128 Million
Q1 2023

May 15, 2023
BUY
$46.97 - $58.27 $2.37 Million - $2.94 Million
50,498 Added 2.46%
2,102,458 $102 Million
Q4 2022

Feb 14, 2023
BUY
$52.05 - $65.0 $8.86 Million - $11.1 Million
170,166 Added 9.04%
2,051,960 $124 Million
Q3 2022

Nov 15, 2022
SELL
$25.16 - $60.63 $9.17 Million - $22.1 Million
-364,279 Reduced 16.22%
1,881,794 $114 Million
Q2 2022

Aug 15, 2022
SELL
$22.73 - $39.98 $2.76 Million - $4.86 Million
-121,510 Reduced 5.13%
2,246,073 $61 Million
Q1 2022

May 16, 2022
BUY
$30.27 - $49.22 $11.9 Million - $19.4 Million
394,633 Added 20.0%
2,367,583 $86.6 Million
Q4 2021

Feb 14, 2022
BUY
$42.11 - $73.26 $23.9 Million - $41.6 Million
567,706 Added 40.4%
1,972,950 $97.5 Million
Q3 2021

Nov 15, 2021
BUY
$48.2 - $78.89 $8.52 Million - $13.9 Million
176,765 Added 14.39%
1,405,244 $100 Million
Q2 2021

Aug 16, 2021
BUY
$21.63 - $57.65 $523,164 - $1.39 Million
24,187 Added 2.01%
1,228,479 $63.2 Million
Q1 2021

May 17, 2021
BUY
$11.0 - $28.24 $6.54 Million - $16.8 Million
594,142 Added 97.38%
1,204,292 $30.3 Million
Q4 2020

Feb 16, 2021
SELL
$10.12 - $13.94 $6.31 Million - $8.69 Million
-623,301 Reduced 50.53%
610,150 $7.33 Million
Q3 2020

Nov 10, 2020
SELL
$9.93 - $13.47 $2.03 Million - $2.75 Million
-204,174 Reduced 14.2%
1,233,451 $12.3 Million
Q2 2020

Aug 14, 2020
BUY
$9.56 - $12.51 $3.67 Million - $4.81 Million
384,177 Added 36.47%
1,437,625 $15 Million
Q1 2020

May 11, 2020
BUY
$7.54 - $15.77 $7.94 Million - $16.6 Million
1,053,448 New
1,053,448 $11.3 Million

Others Institutions Holding PRTA

# of Institutions
184
Shares Held
42.7M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $714M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email